Precision oncology

Show results for

Unknown (10311)
Genomics (363)
Transcriptomics (82)
Proteomics (76)
Other (10)
Genomic (4)
Clinical (3)
Methylation profiling (3)
Metabolomics (2)
Models (1)

Organisms

Homo sapiens (201)
Schizosaccharomyces pombe (70)
Oryza sativa Indica Group (70)
Sinorhizobium meliloti BL225C (70)
Sus scrofa domesticus (70)
Ostreococcus tauri (70)
Saccharomyces cerevisiae (70)
Staphylococcus aureus (70)
Rattus norvegicus (70)
Escherichia coli (70)
Candida albicans (70)
Cyanophora paradoxa (70)
Entamoeba histolytica (70)
Physcomitrium patens (70)
Methylohalobius crimeensis 10Ki (70)
Homo sapiens (70)
Lotus japonicus (70)
Shigella flexneri (70)
Ctenopharyngodon idella (70)
Danio rerio (70)
Allexis (70)
Shigella (70)
Pseudomonas putida KT2440 (70)
Helicobacter pylori 26695 (70)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (70)
Zea mays (70)
Meleagris gallopavo (70)
Medicago truncatula (70)
Mus musculus (7)
Canis lupus (1)

Organisms

Homo sapiens (143)
Mus musculus (14)

Repository

ENA (254)
EGA (103)
geo (92)
pride (70)
biostudies-arrayexpress (9)
dbGaP (4)
iProX (3)
MassIVE (3)
MetaboLights (2)
BioModels (1)

Tissue

Epithelial cell (17)
Cell culture (16)
Blood (5)
Brain (4)
T cell (4)
Lymph node (3)
Macrophage (3)
Blood plasma (3)
Dendritic cell (3)
B cell (3)
Breast cancer cell (2)
Malignant cell (2)
Breast (2)
Extracellular vesicle (2)
Myeloid cell (2)
Cell suspension culture (2)
Lung (2)
Urinary bladder (2)
Liver (2)
Monocyte (2)
Colon (2)
Transitional cell carcinoma cell (1)
Renal cell carcinoma cell (1)
TEX cell (1)
MOLM-14 cell (1)
MV-4-11 cell (1)
MOLM-16 cell (1)
Urinary bladder carcinoma cell line (1)
Type I cell of adrenal cortex (1)
Glioma cell (1)

Disease

Breast cancer (6)
Lung cancer (5)
Urinary bladder cancer (5)
Acute leukemia (4)
Skin melanoma (2)
Non-small cell lung carcinoma (2)
Brain glioblastoma multiforme (2)
Obesity (2)
Lymphoma (2)
Cancer (2)
Brain cancer (2)
Malignant neoplasm of ovary (2)
Rheumatoid arthritis (2)
Disease free (2)
Colon cancer (2)
Carcinoma, Hepatocellular (1)
Carcinoma (1)
Colorectal Neoplasms (1)
Myasthenia gravis (1)
Esophagus adenocarcinoma (1)
Signet ring cell adenocarcinoma (1)
Stomach cancer (1)
Neck carcinoma (1)
Sarcoma (1)
Prostate cancer (1)
Neuroblastoma (1)
Melanoma (1)
Head and neck squamous cell carcinoma (1)
Pancreatic cancer (1)
Colorectal cancer (1)

Technology Type

Mass Spectrometry (70)
Shotgun proteomics (26)
Bottom-up proteomics (24)
Data-dependent acquisition (13)
Data-independent acquisition (12)
SWATH MS (5)
Gel-based experiment (4)
Mass spectrometry (2)
DiaPASEF (2)
SRM/MRM (2)
Affinity purification coupled with mass spectrometry proteomics (2)
ABI_SOLID, Illumina HiSeq 2000, Illumina 450K, AB 5500xl Genetic Analyzer, AB 5500 Genetic Analyzer, ILLUMINA (1)
Illumina HiSeq 2500, ILLUMINA (1)
Illumina HiSeq 2500 (1)
Glycoproteomics (1)
Immunopeptidomics (1)
Top-down proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (2)
Illumina HiSeq 4000 (2)
TimsTOF SCP (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina HiSeq 2000 (1)
TimsTOF Ultra (Bruker Daltonics timsTOF series) (1)
TimsTOF (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2024 (37)
2026 (35)
2025 (28)
2022 (22)
2023 (19)
2017 (7)
2018 (6)
2021 (6)
2019 (6)
2020 (5)
2014 (4)
2015 (3)
2010 (1)

CHEBI ID

CHEBI:137604 (1)
CHEBI:134487 (1)
CHEBI:65294 (1)
CHEBI:65302 (1)
CHEBI:134270 (1)
CHEBI:134451 (1)
CHEBI:86472 (1)
CHEBI:134271 (1)
CHEBI:85851 (1)
CHEBI:66862 (1)
CHEBI:64431 (1)
CHEBI:64519 (1)
CHEBI:64525 (1)
CHEBI:64526 (1)
CHEBI:64446 (1)
CHEBI:64504 (1)
CHEBI:64523 (1)
CHEBI:64433 (1)
CHEBI:66857 (1)
CHEBI:85766 (1)
CHEBI:64516 (1)
CHEBI:64517 (1)
CHEBI:66848 (1)
CHEBI:66849 (1)
CHEBI:66850 (1)
CHEBI:65303 (1)

Metabolite Name

Phosphatidylethanolamine(38:4) (1)
Phosphatidylethanolamine(36:4) (1)
Phosphatidylethanolamine(36:1) (1)
Phosphatidylcholine(40:8) (1)
Phosphatidylcholine(40:4) (1)
Phosphatidylcholine(38:6) (1)
Phosphatidylcholine(38:5) (1)
Phosphatidylcholine(36:3) (1)
Phosphatidylcholine(36:2) (1)
Phosphatidylcholine(35:2) (1)
Phosphatidylcholine(34:1) (1)
Phosphatidylcholine(34:2) (1)
Phosphatidylcholine(33:5) (1)
Phosphatidylcholine(32:2) (1)
Phosphatidylcholine(32:0) (1)
Phosphatidylcholine(31:0) (1)
Phosphatidylcholine(33:1) (1)
Phosphatidylcholine(30:0) (1)
Phosphatidylcholine(28:0) (1)
Phosphatidylcholine(40:6) (1)
Phosphatidylcholine(38:3) (1)
Phosphatidylcholine(38:4) (1)
Phosphatidylcholine(36:1) (1)
Phosphatidylcholine(36:5) (1)
Phosphatidylcholine(32:1) (1)
Phosphatidylcholine(30:1) (1)
5-Amino-1,3,4-thiadiazole-2-thiol (1)

First Public Date

2026 (48)
2024 (47)
2023 (45)
2025 (38)
2022 (22)
2021 (15)
2020 (13)
2019 (10)
2017 (7)
2014 (4)
2018 (3)
2015 (2)

Modelling Approach

Boolean model (1)

Study status

Withdrawn (2)
Not yet recruiting (1)

Lab affiliation

UHN (3)
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch (3)
European Institute of Oncology (2)
Section for Translational Surgical Oncology and Biobanking, Department of Surgery, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck, Germany (2)
Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC) (1)
1. Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark; 2. Proteomics and Singal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
Breast Cancer Clinical Research Unit Centro Nacional de Investigaciones Oncológicas – CNIO Madrid, Spain. (1)
Pediatric Precision Oncology Lab (PPOL), Department of Biomolecular Medicine, Faculty of Medicine & Health Sciences, Ghent University, Corneel Heymanslaan 10, 9000 Ghent, Belgium (1)
Department of Oncology-Pathology, Karolinska Institutet and Science for Life Laboratory (lab head) (1)
Department of Translational Medicine, Lund University, Sweden (1)
Department of Oncology-Pathology, Karolinska Institutet Stockholm, Sweden (1)
Department of Biochemistry, Faculty of Medicine & Dentistry, University of Alberta, Canada; Department of Oncology, Faculty of Medicine & Dentistry, University of Alberta, Canada (1)
Englander Institute of Precision Medicine Professor Radiation Oncology Professor Physiology and Biophysics Weill Cornell Medicine 1300 York Avenue Room E215 New York, NY 10065 tel 646-962-2160 (1)
Maria Sklodowska-Curie National Research Institute of Oncology (1)
Dept. Oncology-Pathology, Scilifelab, Karolinska Institutet, Sweden (1)
Novo Nordisk Foundation Center for Protein Research, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (1)
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou 510060, P. R. China. (1)
Dept. Exp. Oncology Istituto Europeo di Oncologia Via Giuseppe Ripamonti, 435, 20141 Milano (1)
Department of Medicine | Cardiology | Cardiometabolic Precision Medicine Program Department of Systems Biology Herbert Irving Comprehensive Cancer Center | Precision Oncology and Systems Biology Program Data Science Institute | Health Analytics Center Columbia Stem Cell Initiative Columbia University Irving Medical Center (1)
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London (1)
Maria Sklodowska‐Curie National Research Institute of Oncology, Gliwice Poland (1)
Assistant Professor Department of Medicine | Cardiology | Cardiometabolic Precision Medicine Program Department of Systems Biology Herbert Irving Comprehensive Cancer Center | Precision Oncology and Systems Biology Program Data Science Institute | Health Analytics Center Columbia Stem Cell Initiative Columbia University Irving Medical Center 630 West 168th Street, P&S 10-401, New York, NY 10032 (1)
Translational Oncology Research Group, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Scotland, United Kingdom (1)
1.Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology, Xiangya Hospital & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China (1)
Maria Sklodowska Curie National Research Institute of Oncology, Gliwice Branch (1)
Associate Professor, Department of Biochemistry, Faculty of Medicine & Dentistry, University of Alberta (1)
Laboratory of Cancer Metabolism, Department of Experimental Oncology, Maria Sklodowska-Curie National Research Institute of Oncology (1)
University of Bern, Inselspital (1)
Department of oncology and pathology, Karolinska Inatitutet, Stochkholm, Sweden (1)
German Cancer Research Center Heidelberg, Division: Systems Biology of Singal Transduction (1)

Keyword

IRDye800 (1)
Light-CT Scanner (1)
Tumour detection (1)
Hyperspectral imaging (1)
Fluorescence (1)
Antibody (1)
Bevacizumab (1)

IsPrivate

False (1)

Modification

N6 (2)

Study type

Transcription profiling by array (4)
Exome sequencing (2)
Interventional (2)
ATAC-seq (1)
ChIP-seq (1)
RNA-seq of coding RNA (1)
Observational (1)

Release Date

2025 (2225)
2024 (1453)
2022 (1407)
2023 (1402)
2021 (1215)
2020 (807)
2019 (502)
2018 (365)
2026 (323)
2017 (275)
2016 (159)
2015 (100)
2014 (46)
2013 (10)
2012 (10)
2010 (7)
2011 (5)
2009 (3)
2006 (2)
2008 (1)
2007 (1)
2004 (1)

Location

Hong Kong (1)
United States (1)

Previous page
1 / 1086
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 1086
Next page

Sort by:

Relevance

Page size

VA APOLLO Project - Research for Precision Oncology (RePOP)

The Research for Precision Oncology Program (RePOP) is a research activity that establishes a cohort of Veterans diagnosed with cancer and who have had genomic analyses performed on their tumor tissue as part of standard of care. All data relevant to a patient's cancer and cancer care will be...

phs001374 | dbGaP

Synthetic lethality-mediated precision oncology via the tumor transcriptome

PRJNA700986 | ENA

Patient-derived micro-organospheres (MOS) enable clinical precision oncology

PRJNA763787 | ENA

A Single-Cell Tumor Immune Atlas for Precision Oncology

PRJNA666613 | ENA

Applying Precision Oncology Principles in Radiation Oncology.

Not available

S-EPMC7446508 | biostudies-literature

AI-based digital pathology and spatial proteomics enable precision oncology: A case report of recurrent melanoma in a young patient

Background: Metastatic melanoma presents clinical challenges due to tumor heterogeneity and resistance mechanisms, especially when standard treatments fail. Recent advances in artificial intelligence (AI) and spatial proteomics have opened new avenues for precision oncology. Exploring these principl...

ORGANISM(S): Homo sapiens (Human)

2026-09-07 | PXD073928 | Pride

The OncoLoop Network-based Precision Oncology Framework

PRJNA774549 | ENA

Towards Optimization of Precision Oncology in Metastatic Uterine Tumors

PRJNA892975 | ENA

OncoKB: A Precision Oncology Knowledge Base.

Not available

S-EPMC5586540 | biostudies-literature

Towards Optimization of Precision Oncology in Metastatic Uterine Tumors

PRJNA887066 | ENA

Previous page
1 / 1086
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 1086
Next page

Sort by:

Relevance

Page size

10855 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Modification

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets